But with high costs, limited access, and potential side effects to consider, its understandable that many people are looking for alternative ways to support weight loss and appetite control
Track your injections in a simple notebook or phone app, recording when you actually inject versus when you planned to inject
Additionally, we cannot rule out confounders that were not assessed, such as genetic predisposition (beyond the investigated SNPs) and environmental factors
Efficacy concerns
Clinicians must be vigilant and monitor this potentially serious adverse event
Initially developed for type 2 diabetes, GLP-1RAs have demonstrated robust weight loss in randomized controlled trials and real-world settings, leading to their repositioning as cornerstone obesity treatments ( Human metabolic studies consistently show that reductions in energy intake account for most of the weight loss observed during GLP-1RA therapy, whereas increases in resting energy expenditure are modest or absent ( Beyond total weight loss, the quality of weight loss has become an increasingly important clinical concern